Vitamin A deficiency caused an eye problem in a young New York City woman, her doctors report. The woman was 24 and pregnant. She went to Columbia University Medical Center, complaining of a decline in vision. She said it had been getting worse for the last 7 weeks, especially at night. Doctors tested her blood and found that her vitamin A was extremely low. After she took supplements, she could see normally again. The woman had anorexia nervosa. She told doctors she had eaten little except white onions, white potatoes and red meat for the last 7 years. Doctors also said her body could have been taking vitamin A from her blood to nourish the fetus. The journal Lancet published the study online July 18.
Content restricted. Requires subscription
New government rules will require insurance plans to offer preventive health care with no out-of-pocket cost to patients. The rules were released July 14, the Associated Press (AP) reported. They cover tests for colon and breast cancer, diabetes, high cholesterol and high blood pressure. Pregnant women will get tests for vitamin deficiencies. Routine vaccinations will be covered. Children also will get routine doctor visits, plus hearing and eye tests. The rules also cover counseling to help children stay at a healthy weight and help people quit smoking. Further rules for women’s health screening are still being developed. The benefits take effect when plans are renewed, in most cases January 1. Some large employer plans will be exempt for now. But they could have to comply later as they make other changes to their plans, AP reported.
Content restricted. Requires subscription
Content restricted. Requires subscription
Current guidelines for cholesterol screening in children may miss many problems, a new study finds. The study used records for more than 20,000 West Virginia children. They had been tested as part of a heart disease prevention project in the state. The project tested all children in fifth grade. About 71% met standard guidelines to get cholesterol tests. They had parents or grandparents with early heart disease, or parents with total cholesterol levels above 240 milligrams per deciliter (mg/dL) of blood. Tests found that about 8.3% of these children had abnormal LDL (“bad cholesterol”), above 130 mg/dL. Researchers also looked at results for children who did not meet guidelines for testing. They actually had more problems than the other group. About 9.5% had high LDL. The authors said current guidelines should be changed. They said all children should be tested.
Content restricted. Requires subscription
Vitamin D may help to protect the brain, two new studies suggest. One study looked at blood levels of vitamin D in 858 older adults. They also were given tests of various mental abilities. The study lasted 6 years. In that time, people with very low vitamin D levels were 60% more likely than others to have major declines in thinking, learning and memory. They were 31% more likely to have losses in executive function. This is the brain function that deals with organizing and planning. Study results appeared in the journal Archives of Internal Medicine. The other study was in the Archives of Neurology. It included nearly 3,200 older adults. They did not have Parkinson’s disease when the study began. During the next 29 years, 50 developed the disease. People with the highest vitamin D levels were 67% less likely to develop Parkinson’s than people with the lowest levels.
Content restricted. Requires subscription
Content restricted. Requires subscription
People with diabetes have a higher risk of heart attack and death if they use the drug rosiglitazone (Avandia), a research review finds. Scientists from the U.S. Food and Drug Administration (FDA) did the review of prior research. It was released July 9. This week, the FDA is assembling a group of outside experts to look at the evidence about Avandia. FDA scientists don’t all agree on how much risk the drug presents, an official told the Associated Press. One FDA scientist involved in the report criticized a major study often cited as supporting Avandia’s safety. He said the study has serious flaws. The experts will vote this week on whether to recommend more restrictions for Avandia. The FDA could require stronger warning labels, limit who can get the drug, or remove it from the market. The FDA does not have to follow the advice of outside experts, but it often does.
Content restricted. Requires subscription
Content restricted. Requires subscription
A few surgeons are trying to expand who is eligible for weight loss surgery. The aim is to help people with uncontrolled diabetes. The Associated Press (AP) wrote July 8 about a woman who got the procedure. Weight loss surgery includes gastric bypass, stomach stapling and gastric banding. Guidelines set limits on who should have these procedures. They are recommended for people with a body mass index (BMI) of 40 or more. Usually, this is at least 100 pounds overweight. The surgery also can be done if someone has a BMI of 35 or more and an obesity-related health problem, such as diabetes. The woman profiled by AP had a lower BMI, 31.8. But she could not control her blood sugar. After gastric bypass, she is 50 pounds lighter. She has no need for diabetes medicine. Her surgery was done at New York Presbyterian/Weill Cornell Medical Center.
Content restricted. Requires subscription
Taking fish oil supplements may reduce breast cancer risk, a study suggests. The study included more than 35,000 women who were past menopause and had no previous breast cancer. They were asked about their use of supplements, including fish oil. Researchers kept track of them for 6 years. In that time, 880 women were diagnosed with breast cancer. Those who had taken fish oil regularly were 32% less likely to develop breast cancer than other women. The difference applied only to invasive ductal cancer, the most common type. Researchers said it’s not clear why fish oil might affect breast cancer risk. They said more research is needed, including a study that randomly assigns women to take fish oil or fake pills. The study appeared in the journal Cancer Epidemiology, Biomarkers & Prevention. HealthDay News wrote about it July 8.
Content restricted. Requires subscription